Breast Imaging Market Driven by Growing Demand for Early Diagnosis of Breast Cancer

 

Market Overview:

The global breast imaging market is expected to exhibit a strong 8.5% CAGR over the forecast period from 2017 to 2023, according to the latest research report from Market Research Future (MRFR). The global breast imaging market is mainly driven by the growing prevalence of breast cancer and the rising demand for effective breast imaging methodologies that provide accurate imaging capabilities and allow early diagnosis of breast cancer. The report provides a thorough overview of the major drivers and restraints affecting the global breast imaging market, allowing the reader to form a comprehensive picture of the market based on its most prominent motivating factors. The historical growth trajectory of the global breast imaging market is studied in detail in the report in order to provide pointers as to the major growth trends exhibited by the market. Along with the analysis of the major drivers and restraints affecting the market, this provides readers a thorough understanding of the path taken by the market in reaching its current standing.

The growing prevalence of breast cancer among women is the major driver for the global Breast Imaging Market. Breast cancer is the second most prevalent type of cancer among women, with more than 200,000 new cases diagnosed every year. Breast cancer has also become a major public issue in recent years, with a number of healthcare organizations and celebrities joining the cause to promote breast cancer and raise funds for poor patients and further product development to make breast imaging easier and more accurate. The growing demand for precise diagnostic tools that can diagnose breast cancer at an early stage is likely to be a major driver for the global breast imaging market over the forecast period. Early diagnosis of cancer is highly important in managing the disease and ensuring a positive prognosis, leading to a growing demand for product development in the breast imaging market targeted at developing devices that can detect tumors when they are at their smallest.

On the other hand, the high costs of breast imaging techniques are the major restraint against the global breast imaging market. Lack of awareness about breast imaging and breast cancer is also a major restraint against the global breast imaging market.

Competitive Analysis:

Sonocine Inc., Toshiba Corporation, Gamma Medica Inc., Aurora Imaging Technology Inc., Dilon Technologies Inc., Fujifilm Holdings Corporation, Hologic Inc., Koninklijke Philips N.V., Siemens, and GE.

Segmentation:

The global breast imaging market is segmented on the basis of type, application, end user, and region.

On the basis of type, the breast imaging market is segmented into mammography, CT, PET, MRI, ultrasound, breast biopsy, tactile imaging, and others. Mammography is further segmented into film-screen mammography, full-field digital mammography (FFDM), 3D mammography, scintimammography or molecular breast imaging, and others.Breast biopsy is further segmented into image-guided breast biopsy, tactic core biopsy, ultrasound-guided core biopsy, and others.

On the basis of application, the global breast imaging market is segmented into breast cancer diagnosis, post-neoadjuvant chemotherapy, metastatic axillary adenocarcinoma, and others.

On the basis of end user, the market is segmented into hospitals, diagnostic centers, and others.

Regional Analysis:

The Americas is the largest regional market for breast imaging. The widespread awareness about breast cancer in the region has been a primary driver for the breast imaging market, as it has driven consistent product development in the breast imaging market. Women in the country don’t view breast cancer as a taboo and are proactive in fighting the disease ontheir own terms. This has driven significant growth of the breast imaging market. The growing prevalence of breast cancer in the region is also likely to remain a major driver for the breast imaging market in the Americas.

Europe holds the second largest share in the global breast imaging market, followed by Asia Pacific. China, Japan, and India are likely to emerge as important markets in the coming years, enabling steady growth of the breast imaging market in Asia Pacific.